220 related articles for article (PubMed ID: 22378037)
41. Lack of Suppression of Aldosterone Production Leads to Salt-Sensitive Hypertension in Female but Not Male Balb/C Mice.
Faulkner JL; Harwood D; Bender L; Shrestha L; Brands MW; Morwitzer MJ; Kennard S; Antonova G; Belin de Chantemèle EJ
Hypertension; 2018 Dec; 72(6):1397-1406. PubMed ID: 30571230
[TBL] [Abstract][Full Text] [Related]
42. Abnormal regulation of proximal tubule renin mRNA in the Dahl/Rapp salt-sensitive rat.
Tank JE; Moe OW; Henrich WL
Kidney Int; 1998 Nov; 54(5):1608-16. PubMed ID: 9844137
[TBL] [Abstract][Full Text] [Related]
43. Effect of the angiotensinogen genotype on experimental hypertension in mice.
Handtrack C; Cordasic N; Klanke B; Veelken R; Hilgers KF
J Mol Med (Berl); 2007 Apr; 85(4):343-50. PubMed ID: 17333097
[TBL] [Abstract][Full Text] [Related]
44. Blockade of sodium-glucose cotransporter 2 suppresses high glucose-induced angiotensinogen augmentation in renal proximal tubular cells.
Satou R; Cypress MW; Woods TC; Katsurada A; Dugas CM; Fonseca VA; Navar LG
Am J Physiol Renal Physiol; 2020 Jan; 318(1):F67-F75. PubMed ID: 31682172
[TBL] [Abstract][Full Text] [Related]
45. Salt-sensitive hypertension resulting from nitric oxide synthase inhibition is associated with loss of regulation of angiotensin II in the rat.
Hodge G; Ye VZ; Duggan KA
Exp Physiol; 2002 Jan; 87(1):1-8. PubMed ID: 11805851
[TBL] [Abstract][Full Text] [Related]
46. Targeting of hepatic angiotensinogen using chemically modified siRNAs results in significant and sustained blood pressure lowering in a rat model of hypertension.
Olearczyk J; Gao S; Eybye M; Yendluri S; Andrews L; Bartz S; Cully D; Tadin-Strapps M
Hypertens Res; 2014 May; 37(5):405-12. PubMed ID: 24335718
[TBL] [Abstract][Full Text] [Related]
47. Intrarenal mouse renin-angiotensin system during ANG II-induced hypertension and ACE inhibition.
Gonzalez-Villalobos RA; Satou R; Ohashi N; Semprun-Prieto LC; Katsurada A; Kim C; Upchurch GM; Prieto MC; Kobori H; Navar LG
Am J Physiol Renal Physiol; 2010 Jan; 298(1):F150-7. PubMed ID: 19846570
[TBL] [Abstract][Full Text] [Related]
48. Canagliflozin Prevents Intrarenal Angiotensinogen Augmentation and Mitigates Kidney Injury and Hypertension in Mouse Model of Type 2 Diabetes Mellitus.
Woods TC; Satou R; Miyata K; Katsurada A; Dugas CM; Klingenberg NC; Fonseca VA; Navar LG
Am J Nephrol; 2019; 49(4):331-342. PubMed ID: 30921791
[TBL] [Abstract][Full Text] [Related]
49. Attenuation of accelerated renal cystogenesis in Pkd1 mice by renin-angiotensin system blockade.
Fitzgibbon WR; Dang Y; Bunni MA; Baicu CF; Zile MR; Mullick AE; Saigusa T
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F210-F218. PubMed ID: 29021226
[TBL] [Abstract][Full Text] [Related]
50. Renal tubule angiotensin II type 1 receptor-associated protein promotes natriuresis and inhibits salt-sensitive blood pressure elevation.
Wakui H; Uneda K; Tamura K; Ohsawa M; Azushima K; Kobayashi R; Ohki K; Dejima T; Kanaoka T; Tsurumi-Ikeya Y; Matsuda M; Haruhara K; Nishiyama A; Yabana M; Fujikawa T; Yamashita A; Umemura S
J Am Heart Assoc; 2015 Mar; 4(3):e001594. PubMed ID: 25792129
[TBL] [Abstract][Full Text] [Related]
51. Titrating angiotensinogen in salt sensitive hypertension.
Luft FC
J Mol Med (Berl); 2007 Apr; 85(4):313-6. PubMed ID: 17356844
[No Abstract] [Full Text] [Related]
52. The establishment of a primary culture system of proximal tubule segments using specific markers from normal mouse kidneys.
Kamiyama M; Garner MK; Farragut KM; Kobori H
Int J Mol Sci; 2012; 13(4):5098-5111. PubMed ID: 22606032
[TBL] [Abstract][Full Text] [Related]
53. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease.
Loghman-Adham M; Soto CE; Inagami T; Cassis L
Am J Physiol Renal Physiol; 2004 Oct; 287(4):F775-88. PubMed ID: 15187005
[TBL] [Abstract][Full Text] [Related]
54. Angiotensinogen concentrations and renin clearance : implications for blood pressure regulation.
Bohlender J; Ménard J; Ganten D; Luft FC
Hypertension; 2000 Mar; 35(3):780-6. PubMed ID: 10720595
[TBL] [Abstract][Full Text] [Related]
55. Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis-Brief Report.
Ye F; Wang Y; Wu C; Howatt DA; Wu CH; Balakrishnan A; Mullick AE; Graham MJ; Danser AHJ; Wang J; Daugherty A; Lu HS
Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):150-155. PubMed ID: 30567480
[TBL] [Abstract][Full Text] [Related]
56. Functional Exploration of Conserved Sequences in the Distal Face of Angiotensinogen-Brief Report.
Amioka N; Wu CH; Sawada H; Ito S; Pettey AC; Wu C; Moorleghen JJ; Howatt DA; Graf GA; Vander Kooi CW; Daugherty A; Lu HS
Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1524-1532. PubMed ID: 37345525
[TBL] [Abstract][Full Text] [Related]
57. Heterogeneous nuclear ribonucleoprotein F suppresses angiotensinogen gene expression and attenuates hypertension and kidney injury in diabetic mice.
Lo CS; Chang SY; Chenier I; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
Diabetes; 2012 Oct; 61(10):2597-608. PubMed ID: 22664958
[TBL] [Abstract][Full Text] [Related]
58. Regulation of aortic atrial natriuretic factor and angiotensinogen in experimental hypertension.
Ogawa T; Linz W; Schölkens BA; de Bold AJ
J Cardiovasc Pharmacol; 1998 Dec; 32(6):1001-8. PubMed ID: 9869508
[TBL] [Abstract][Full Text] [Related]
59. Strong and Sustained Antihypertensive Effect of Small Interfering RNA Targeting Liver Angiotensinogen.
Uijl E; Mirabito Colafella KM; Sun Y; Ren L; van Veghel R; Garrelds IM; de Vries R; Poglitsch M; Zlatev I; Kim JB; Hoorn EJ; Foster D; Danser AHJ
Hypertension; 2019 Jun; 73(6):1249-1257. PubMed ID: 31030610
[TBL] [Abstract][Full Text] [Related]
60. Involvement of complement 3 in the salt-sensitive hypertension by activation of renal renin-angiotensin system in spontaneously hypertensive rats.
Negishi E; Fukuda N; Otsuki T; Katakawa M; Komatsu K; Chen L; Tanaka S; Kobayashi H; Hatanaka Y; Ueno T; Endo M; Mashimo T; Nishiyama A; Abe M
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1747-F1758. PubMed ID: 30256128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
